ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

30 Nov 2021

ECO Animal Health - HY Results - Investor Presentation video - 30 November 2021

We hosted an investor presentation with the management of ECO Animal Health Group plc.

Marc Loomes, CEO and Chris Wilks, CFO introduced key aspects of their equity story, running through the detail of their Interim Results for the period ended 30 September. In particular they discussed the pork market volatility in China, the performance of the business in the Rest of the World in the face of supply chain disruptions, cash, and the potential of the company's R&D programme.

The full video recording is available below (approximate length 54 minutes).

0:03 introduction (Marc Loomes, CEO)
0:55 Financial Highlights (Chris Wilks, CFO)
19:11 China Pork Production discussion
26:53 R&D programme
32:23 Governance / CSR
34:43 Other Matters and Conclusion
38:55 Investor Questions & Answers

Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 3rd Floor, 80 Cheapside, London, EC2V 6EE

Website design & development by Breckenridge